62 A sub study of CRISP AMI showed a trend towards reduced mortality at 6 months with use of IABP in patients with a large MI (ST elevation > 15 mm at baseline) and persistent ischaemia (ST resolution <50% post revascularisation) 63 PROTECT II was a randomised, prospective, multicenter study which explored the use of the of Impella CP 2.5 L in a population of patients undergoing high risk PCI.
← all excerpts
The role of mechanical support devices during percutaneous coronary intervention.
1
—
—